Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Ocaratuzumab> ?p ?o }
Showing triples 1 to 50 of
50
with 100 triples per page.
- Ocaratuzumab abstract "Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders. The antibody is engineered for enhanced affinity to the CD20 antigen on B-lymphocytes, increased antibody-dependent cell-mediated cytotoxicity (ADCC), and for improved treatment of low-affinity FcγRIIIa allotypes.Phase I/II trials in relapsed/refractory follicular lymphoma have been completed in the United States (US) and Japan, and a Phase I trial was conducted in US rheumatoid arthritis patients. Phase III development in relapsed follicular lymphoma patients is underway. Many patients relapse following currently available treatments, and a significant need for new effective treatment exists, particularly for patients with low-affinity FcγRIIIa allotypes. In pre-clinical studies, ocaratuzumab was shown to have 13 to 20 fold greater affinity for CD20 and 6 fold more potent ADCC as compared to rituximab. Additional development in other oncology and rheumatology indications will also be pursued, as well as subcutaneous formations for patient convenience.This drug is currently being developed by Mentrik Biotech, LLC.".
- Ocaratuzumab atcPrefix "none".
- Ocaratuzumab casNumber "1169956-08-4".
- Ocaratuzumab wikiPageID "35610497".
- Ocaratuzumab wikiPageLength "4655".
- Ocaratuzumab wikiPageOutDegree "7".
- Ocaratuzumab wikiPageRevisionID "587857560".
- Ocaratuzumab wikiPageWikiLink Antibody-dependent_cell-mediated_cytotoxicity.
- Ocaratuzumab wikiPageWikiLink CD20.
- Ocaratuzumab wikiPageWikiLink Cancer.
- Ocaratuzumab wikiPageWikiLink Category:Monoclonal_antibodies.
- Ocaratuzumab wikiPageWikiLink Follicular_lymphoma.
- Ocaratuzumab wikiPageWikiLink Rheumatoid_arthritis.
- Ocaratuzumab wikiPageWikiLink Rituximab.
- Ocaratuzumab wikiPageWikiLinkText "Ocaratuzumab".
- Ocaratuzumab atcPrefix "none".
- Ocaratuzumab c "6464".
- Ocaratuzumab casNumber "1169956".
- Ocaratuzumab chemspiderid "NA".
- Ocaratuzumab h "10016".
- Ocaratuzumab hasPhotoCollection Ocaratuzumab.
- Ocaratuzumab molecularWeight "145.3".
- Ocaratuzumab n "1712".
- Ocaratuzumab o "2010".
- Ocaratuzumab s "44".
- Ocaratuzumab source "zu".
- Ocaratuzumab target CD20.
- Ocaratuzumab type "mab".
- Ocaratuzumab wikiPageUsesTemplate Template:Drugbox.
- Ocaratuzumab wikiPageUsesTemplate Template:Monoclonals_for_tumors.
- Ocaratuzumab subject Category:Monoclonal_antibodies.
- Ocaratuzumab hypernym Antibody.
- Ocaratuzumab type Article.
- Ocaratuzumab type ChemicalSubstance.
- Ocaratuzumab type Drug.
- Ocaratuzumab type Antibody.
- Ocaratuzumab type Article.
- Ocaratuzumab type Chemical.
- Ocaratuzumab type Drug.
- Ocaratuzumab type ChemicalObject.
- Ocaratuzumab type Thing.
- Ocaratuzumab type Q8386.
- Ocaratuzumab comment "Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders.".
- Ocaratuzumab label "Ocaratuzumab".
- Ocaratuzumab sameAs أوكاراتوزوماب.
- Ocaratuzumab sameAs m.0jkw1c8.
- Ocaratuzumab sameAs Q7075663.
- Ocaratuzumab sameAs Q7075663.
- Ocaratuzumab wasDerivedFrom Ocaratuzumab?oldid=587857560.
- Ocaratuzumab isPrimaryTopicOf Ocaratuzumab.